Advertisement

Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Organisation › Details

Celgene Corporation (Nasdaq: CELG)

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. *

 

Period Start 1986-01-01 splitoff
  Group Bristol-Myers Squibb (BMS) (Group)
  Predecessor Celanese (Group)
Products Industry pharmaceutical
  Industry 2 cancer drug
     
  Street 86 Morris Avenue
  City 07901 Summit, NJ
  Tel +1-908-673-9000
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
  Currency USD
  Annual sales 898,873,000 (revenue, total, consolidated (2006) 2006-12-31)
  Profit 68,981,000 (2006-12-31)
  Cash 1,982,210,000 (2006-12-31)
     
    * Document for �About Section�: Celgene Corporation. (1/7/18). "Press Release: Celgene to Acquire Impact Biomedicines, Adding Fedratinib to Its Pipeline of Novel Therapies for Hematologic Malignancies". Summit, NJ & San Diego, CA.
     
   
Record changed: 2021-08-19

Advertisement

Picture [iito] Made Without Love 650x80px

More documents for Bristol-Myers Squibb (BMS) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2021 NYC C Lee Hood Speaking 650x300px




» top